rs972892187

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_001099922.3(ALG13):​c.2686G>A​(p.Gly896Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000015 in 1,200,471 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G896D) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000027 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.000014 ( 0 hom. 4 hem. )

Consequence

ALG13
NM_001099922.3 missense

Scores

6
11

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 1.41

Publications

5 publications found
Variant links:
Genes affected
ALG13 (HGNC:30881): (ALG13 UDP-N-acetylglucosaminyltransferase subunit) The protein encoded by this gene is a subunit of a bipartite UDP-N-acetylglucosamine transferase. It heterodimerizes with asparagine-linked glycosylation 14 homolog to form a functional UDP-GlcNAc glycosyltransferase that catalyzes the second sugar addition of the highly conserved oligosaccharide precursor in endoplasmic reticulum N-linked glycosylation. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]
ALG13 Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 36
    Inheritance: XL Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.15829083).
BS2
High Hemizygotes in GnomAdExome4 at 4 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALG13NM_001099922.3 linkc.2686G>A p.Gly896Ser missense_variant Exon 23 of 27 ENST00000394780.8 NP_001093392.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALG13ENST00000394780.8 linkc.2686G>A p.Gly896Ser missense_variant Exon 23 of 27 2 NM_001099922.3 ENSP00000378260.3

Frequencies

GnomAD3 genomes
AF:
0.0000268
AC:
3
AN:
111744
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0000651
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000951
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000238
AC:
4
AN:
167953
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.0000843
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000128
Gnomad NFE exome
AF:
0.0000133
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000138
AC:
15
AN:
1088727
Hom.:
0
Cov.:
29
AF XY:
0.0000113
AC XY:
4
AN XY:
354951
show subpopulations
African (AFR)
AF:
0.0000383
AC:
1
AN:
26079
American (AMR)
AF:
0.00
AC:
0
AN:
34055
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18994
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29848
South Asian (SAS)
AF:
0.00
AC:
0
AN:
51724
European-Finnish (FIN)
AF:
0.0000496
AC:
2
AN:
40325
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4096
European-Non Finnish (NFE)
AF:
0.0000131
AC:
11
AN:
837898
Other (OTH)
AF:
0.0000219
AC:
1
AN:
45708
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000268
AC:
3
AN:
111744
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
33936
show subpopulations
African (AFR)
AF:
0.0000651
AC:
2
AN:
30742
American (AMR)
AF:
0.0000951
AC:
1
AN:
10516
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2648
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3552
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2663
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6002
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
238
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53195
Other (OTH)
AF:
0.00
AC:
0
AN:
1503
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.542
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000189

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Developmental and epileptic encephalopathy, 36 Uncertain:2
Mar 01, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 13, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 896 of the ALG13 protein (p.Gly896Ser). This variant is present in population databases (no rsID available, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with ALG13-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ALG13 protein function. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.086
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.77
CADD
Benign
19
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.44
T;.;.;.;.
FATHMM_MKL
Benign
0.11
N
LIST_S2
Benign
0.70
T;T;.;T;.
M_CAP
Uncertain
0.25
D
MetaRNN
Benign
0.16
T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.1
M;.;.;.;.
PhyloP100
1.4
PrimateAI
Benign
0.29
T
PROVEAN
Uncertain
-2.4
N;.;N;.;.
REVEL
Benign
0.041
Sift
Uncertain
0.027
D;.;D;.;.
Sift4G
Benign
0.10
T;T;T;T;T
Polyphen
0.55
P;P;D;D;D
Vest4
0.21
MVP
0.35
MPC
0.28
ClinPred
0.058
T
GERP RS
2.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.14
gMVP
0.17
Mutation Taster
=92/8
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs972892187; hg19: chrX-110980098; COSMIC: COSV52638954; COSMIC: COSV52638954; API